ReviewFrontiers in immunology2023

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.

Limor Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.